Europe Orthopedic Navigation System Market Worth $22.7Mn By 2022: Grand View Research, Inc.

SAN FRANCISCO, March 3, 2016 /PRNewswire/ --

Europe orthopedic navigation system market is expected to reach USD 22.7 Million by 2022, according to a new report by Grand View Research, Inc. Rising number of target diseases especially in the geriatric population is responsible for the rapid growth of the European orthopedic navigation system market. According to the Executive Agency for Health and Consumers, one in ten people in the geriatric population in Europe is suffering from osteoarthritis.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757 )

Minimal invasion, low post-operative complications associated with computer assisted surgery is anticipated to drive regional market growth over the forecast period. Moreover, the introduction of technologically advanced products is expected to induce demand for orthopedic navigation systems.

Browse full research report with TOC on "Europe Orthopedic Navigation System Market Size and Forecast By Application (Hip Surgery, Knee Surgery), By Country (UK, Germany, Switzerland, France, Spain, Italy, Belgium, Austria, Netherlands, Russia) And Trend Analysis From 2015 To 2022" at: http://www.grandviewresearch.com/industry-analysis/orthopedic-navigation-systems-market                                                                                                                                                                                                          

For instance, in February 2015, Orthokey Italia developed a new version of KiRA system integrating it with iPad to aid in study of kinematics of patient's knee joint. Moreover, favorable reimbursement policies associated with orthopedic navigation system are anticipated to further propel the demand over the forecast period.

Further key findings from the report suggest: 

• Knee surgeries dominated the European orthopedic navigation system market as of 2014, accounting for over 60.0% of the total revenue owing to the rising number of partial & total knee replacement surgeries.
• Hip surgery is anticipated to be growing at a steady rate owing to the rising number of hip replacement surgeries. According to the OECD, hip replacements in the UK are more recurrent and 177 per 100,000 populations in 2014 undergo hip replacement surgeries.
• Germany dominated the overall Europe orthopedic navigation system market in terms of revenue in 2014 at 30.5%. Presence of sophisticated healthcare infrastructure coupled with high healthcare expenditures, and higher volume of joint reconstruction procedures in this region are some factors attributing to the aforementioned conclusion.
• The UK is pegged to witness lucrative growth of over CAGR of 5.0% from 2015 to 2022, owing to the rising prevalence of diseases such as osteoarthritis and increasing usage of computer aided navigation system in knee & hip replacement surgeries. Moreover, high awareness levels, R&D funding, and presence of skilled orthopedic surgeons are likely to fuel future demand.
• Some prominent market participants include Stryker Navigation, B Braun Melsungen AG, Brain Lab, Zimmer Biomet, Microport Medical, Amplitude, De Puy, Medtronic, Orthokey Italia. Market share capitalization via new product development is the most effective sustainability strategy adopted by these players.
• For instance, in May 2015, Medtronic received U.S. FDA approval and introduced its product "StealthStation", a surgical navigation technology in a probe to expand its product portfolio in specialties other than neurosurgery.

Grand View Research has segmented the Europe orthopedic navigation system market on the basis of application and region:

• Europe orthopedic navigation system application outlook (Revenue, USD Million, Volume , 000 units, 2012 - 2022) 
  • Hip surgery
  • Knee surgery
• Europe orthopedic navigation system country outlook (Revenue, USD Million, 2012 - 2022) 
  • UK
  • Germany
  • Switzerland
  • France
  • Spain
  • Italy
  • Belgium
  • Austria
  • Netherlands
  • Russia

Browse related reports by Grand View Research: 

• Preimplantation Genetic Diagnosis Market - http://www.grandviewresearch.com/industry-analysis/preimplantation-genetic-diagnosis-market  
  
• Clinical Decision Support System(CDSS) Market - http://www.grandviewresearch.com/industry-analysis/clinical-decision-support-system-market  

• Renal Disease Treatment Devices Market - http://www.grandviewresearch.com/industry-analysis/renal-disease-treatment-devices-market  

• Pulmonary Arterial Hypertension Market - http://www.grandviewresearch.com/industry-analysis/pulmonary-arterial-hypertension-market        

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs - mediafound.org, blog.grandviewresearchinc                

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com